These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 27385243)

  • 1. Ten-Year Trends In Treatment Services For Children With Attention Deficit Hyperactivity Disorder Enrolled In Medicaid.
    Hoagwood KE; Kelleher K; Zima BT; Perrin JM; Bilder S; Crystal S
    Health Aff (Millwood); 2016 Jul; 35(7):1266-70. PubMed ID: 27385243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Longitudinal Trends in the Diagnosis of Attention-Deficit/Hyperactivity Disorder and Stimulant Use in Preschool Children on Medicaid.
    Davis DW; Feygin Y; Creel L; Williams PG; Lohr WD; Jones VF; Le J; Pasquenza N; Ghosal S; Jawad K; Yan X; Liu G; McKinley S
    J Pediatr; 2019 Apr; 207():185-191.e1. PubMed ID: 30545564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vital Signs: National and State-Specific Patterns of Attention Deficit/Hyperactivity Disorder Treatment Among Insured Children Aged 2-5 Years - United States, 2008-2014.
    Visser SN; Danielson ML; Wolraich ML; Fox MH; Grosse SD; Valle LA; Holbrook JR; Claussen AH; Peacock G
    MMWR Morb Mortal Wkly Rep; 2016 May; 65(17):443-50. PubMed ID: 27149047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality of care for childhood attention-deficit/hyperactivity disorder in a managed care medicaid program.
    Zima BT; Bussing R; Tang L; Zhang L; Ettner S; Belin TR; Wells KB
    J Am Acad Child Adolesc Psychiatry; 2010 Dec; 49(12):1225-37, 1237.e1-11. PubMed ID: 21093772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adherence to Recommended Care Guidelines in the Treatment of Preschool-Age Medicaid-Enrolled Children With a Diagnosis of ADHD.
    Moran A; Serban N; Danielson ML; Grosse SD; Cuffe SP
    Psychiatr Serv; 2019 Jan; 70(1):26-34. PubMed ID: 30373494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology of Treatment for Preschoolers on Kentucky Medicaid Diagnosed with Attention-Deficit/Hyperactivity Disorder.
    Davis DW; Feygin Y; Creel L; Kong M; Jawad K; Sun J; Blum NJ; Lohr WD; Williams PG; Le J; Jones VF; Pasquenza N
    J Child Adolesc Psychopharmacol; 2020 Sep; 30(7):448-455. PubMed ID: 32614247
    [No Abstract]   [Full Text] [Related]  

  • 7. Utilization of pharmacologic treatment in youths with attention deficit/hyperactivity disorder in Medicaid database.
    Winterstein AG; Gerhard T; Shuster J; Zito J; Johnson M; Liu H; Saidi A
    Ann Pharmacother; 2008 Jan; 42(1):24-31. PubMed ID: 18042808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of ADHD treatments: findings from the multimodal treatment study of children with ADHD.
    Jensen PS; Garcia JA; Glied S; Crowe M; Foster M; Schlander M; Hinshaw S; Vitiello B; Arnold LE; Elliott G; Hechtman L; Newcorn JH; Pelham WE; Swanson J; Wells K
    Am J Psychiatry; 2005 Sep; 162(9):1628-36. PubMed ID: 16135621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An assessment of the CHIP/Medicaid quality measure for ADHD.
    Blackburn J; Becker DJ; Morrisey MA; Kilgore ML; Sen B; Caldwell C; Menachemi N
    Am J Manag Care; 2017 Jan; 23(1):e1-e9. PubMed ID: 28141934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination therapy patterns and predictors of ADHD in commercially insured and Medicaid populations.
    Molife C; Bernauer MJ; Farr AM; Haynes VS; Kelsey D
    Postgrad Med; 2012 Sep; 124(5):7-22. PubMed ID: 23095422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medicaid Prior Authorization Policies for Medication Treatment of Attention-Deficit/Hyperactivity Disorder in Young Children, United States, 2015.
    Hulkower RL; Kelley M; Cloud LK; Visser SN
    Public Health Rep; 2017; 132(6):654-659. PubMed ID: 29072963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ADHD medication use, adherence, persistence and cost among Texas Medicaid children.
    Barner JC; Khoza S; Oladapo A
    Curr Med Res Opin; 2011; 27 Suppl 2():13-22. PubMed ID: 21973228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multimodal treatment for ADHD among youths in three Medicaid subgroups: disabled, foster care, and low income.
    dosReis S; Owens PL; Puccia KB; Leaf PJ
    Psychiatr Serv; 2004 Sep; 55(9):1041-8. PubMed ID: 15345765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder.
    Foy JM; Earls MF
    Pediatrics; 2005 Jan; 115(1):e97-104. PubMed ID: 15629972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Second opinions improve ADHD prescribing in a medicaid-insured community population.
    Thompson JN; Varley CK; McClellan J; Hilt R; Lee T; Kwan AC; Lee T; Trupin E
    J Am Acad Child Adolesc Psychiatry; 2009 Jul; 48(7):740-748. PubMed ID: 19465882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis of attention-deficit/hyperactivity disorder and use of psychotropic medication in very young children.
    Rappley MD; Mullan PB; Alvarez FJ; Eneli IU; Wang J; Gardiner JC
    Arch Pediatr Adolesc Med; 1999 Oct; 153(10):1039-45. PubMed ID: 10520611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of long-acting medications on attention-deficit/hyperactivity disorder treatment disparities.
    Saloner B; Fullerton C; McGuire T
    J Child Adolesc Psychopharmacol; 2013 Aug; 23(6):401-9. PubMed ID: 23952187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Moderators and mediators of treatment response for children with attention-deficit/hyperactivity disorder: the Multimodal Treatment Study of children with Attention-deficit/hyperactivity disorder.
    Arch Gen Psychiatry; 1999 Dec; 56(12):1088-96. PubMed ID: 10591284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment modalities among US children diagnosed with attention-deficit hyperactivity disorder: 1995-99.
    Robison LM; Sclar DA; Skaer TL; Galin RS
    Int Clin Psychopharmacol; 2004 Jan; 19(1):17-22. PubMed ID: 15101565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Health care costs of adults treated for attention-deficit/hyperactivity disorder who received alternative drug therapies.
    Wu EQ; Birnbaum HG; Zhang HF; Ivanova JI; Yang E; Mallet D
    J Manag Care Pharm; 2007 Sep; 13(7):561-9. PubMed ID: 17874862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.